John J. Rossi

Dean, Graduate School of Biological Sciences at Beckman Research Institute of the City of Hope

John J. Rossi

John J. Rossi

Dean, Graduate School of Biological Sciences at Beckman Research Institute of the City of Hope

Overview
Career Highlights

MiNA Therapeutics Ltd.
Dicerna Pharmaceuticals, Inc.

RelSci Relationships

950

Number of Boards

9

Birthday

1947

Age

73

Relationships
RelSci Relationships are individuals John J. Rossi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief, Division of Neurosurgery at City of Hope - California

Relationship likelihood: Strong

Director, Diabetes & Metabolism Research Institute at Beckman Research Institute of the City of Hope

Relationship likelihood: Strong

Co-Founder at CS-Keys, Inc.

Relationship likelihood: Strong

Core Leader, Biostatistics & Research Informatics, Support for Data Coordination & Biostatistical Analysis at Beckman Research Institute of the City of Hope

Relationship likelihood: Strong

Partner at Sklar Kirsh LLP

Relationship likelihood: Strong

Medical Oncologist, Hematologist, Provost, Chief Scientific Officer, Irell & Manella Cancer Center Director's Distinguished Chair & Morgan & Helen Chu Director's Chair of the Beckman Research Institute at City of Hope - California

Relationship likelihood: Strong

Board Member at City of Hope - California

Relationship likelihood: Strong

Director at City of Hope - California

Relationship likelihood: Strong

Former President at CNA Insurance Companies

Relationship likelihood: Strong

Head of Medical Genitourinary Oncology at Yeshiva University - Albert Einstein College of Medicine

Relationship likelihood: Strong

Paths to John J. Rossi
Potential Connections via
Relationship Science
You
John J. Rossi
Dean, Graduate School of Biological Sciences at Beckman Research Institute of the City of Hope
Education
Ph.D., Microbial Genetics

The University of Connecticut (UConn) is a public research university in Connecticut. Known as a Public Ivy,[3] UConn was founded in 1881 and is a Land Grant and Sea Grant college & member of the Space Grant Consortium. The institution serves more than 30,000 students on its six campuses, including more than 8,000 graduate students in multiple programs.[4] UConn's main campus is in Storrs, Connecticut. The university's president is Susan Herbst.[5] UConn is one of the founding institutions of the Hartford, Connecticut/Springfield, Massachusetts regional economic and cultural partnership alliance known as New England's Knowledge Corridor. UConn is a member of Universitas 21, a global network of 24 research-intensive universities, who work together to foster global citizenship and institutional innovation through research-inspired teaching and learning, student mobility, connecting students and staff, and promote advocacy for internationalisation.[6] UConn is accredited by the New England Association of Schools and Colleges.

B.A., Biology

UNH is a vibrant place: a land-, sea-, and space-grant university located in Durham, N.H., Concord, N.H. and Manchester, NH.

Postdoc, Biology & Medicine

Brown University is located in historic Providence, Rhode Island and was founded in 1764. It is the seventh-oldest college in the United States. Brown is an independent, coeducational Ivy League institution comprising undergraduate and graduate programs, plus the Alpert Medical School, School of Public Health, School of Engineering, and the School of Professional Studies.

Career History
Dean, Graduate School of Biological Sciences
Current

TO DISCOVER AND TRANSLATE INNOVATIVE LABORATORY FINDINGS INTO NEW CLINICAL TREATMENTS BY USING PRACTICAL APPLICATIONS OF CHEMISTRY, PHYSICS, AND BIOLOGY.

Collaborator, Gene Therapy Research
2016 - Current

American Gene Technologies International, Inc. operates as a gene and cell therapeutics company. It provides treatments for infectious diseases, cancers and monogenic disorders. The company was founded by Jeffrey A. Galvin in 2007 and is headquartered in Rockville, MD.

Adjunct Professor, Division of Biomedical Sciences
2001 - Current

The University of California, Riverside (UCR or UC Riverside), is a public research university and one of the 10 general campuses of the University of California system. The main campus sits on 1,900 acres (769 ha) in a suburban district of Riverside, California, United States, with a branch campus of 20 acres (8 ha) in Palm Desert. Founded in 1907 as the UC Citrus Experiment Station, Riverside, pioneered research in biological pest control and the use of growth regulators responsible for extending the citrus growing season in California from four to nine months. Some of the world's most important research collections on citrus diversity and entomology, as well as science fiction and photography, are located at Riverside.

Boards & Committees
Member, Scientific Advisory Board
Current

Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.

Director
2003 - 2010

CytoGenix, Inc. focuses on development and commercialization of its proprietary technology for identify and silencing disease causing genes and expressing proteins for applications. The company was founded on February 10, 1995 and is headquartered in Houston, TX.

Associate Chair of the Shared Resources Advisory Committee, Comprehensive Cancer Center
2001 - Current

City of Hope National Medical Center, commonly City of Hope, is a private, not-for-profit clinical research center, hospital and graduate medical school located in Duarte, California, United States. The center's main campus resides on 110-acre (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with satellite offices in Monrovia and downtown Los Angeles, and regional fundraising offices throughout the country.

Investments
Details Hidden

MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients’ cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.

Details Hidden

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John J. Rossi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John J. Rossi's profile does not indicate a business or promotional relationship of any kind between RelSci and John J. Rossi.